COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)
22/05/2026
Wegovy ® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EU Novo Nordisk expects to launch Wegovy ® 7.2 mg in a single-dose pen in the EU in Q3 2026 In the STEP UP trial, Wegovy ® 7.2 mg [...]
Leo International Precision Health AG approves cash capital increase excluding subscription rights
22/05/2026
Leo International Precision Health AG / Keyword: Capital measures / Capital increase Leo International Precision Health AG approves cash capital increase excluding subscription rights 22. May 2026 / 20:04 CET/CEST [...]
MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
22/05/2026
Medx Holdings Inc Name Change to Dazed Inc and Lazydaze Coffeeshop Franchise 2026 Summer of Growth Austin, Texas, May 22, 2026 (GLOBE NEWSWIRE) -- MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND [...]
Guerbet: Changes to the Composition of Guerbet’s Board of Directors.
22/05/2026
Changes to the Composition of Guerbet’s Board of Directors _________________________________________________________________ Appointment of Mr. Antoine Fady as an independent director and Chairman of the Board of [...]
Guerbet : Evolution de la composition du Conseil d’administration de Guerbet.
22/05/2026
Evolution de la composition du Conseil d’administration de Guerbet ___________________________________________________________________________ Nomination de Monsieur Antoine Fady en qualité d’administrateur indépendant [...]
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
22/05/2026
PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non- [...]
Vaya Health and Partners Health Management Announce Merger
22/05/2026
Managed care organizations join to bring strength and stability to North Carolina’s public system of behavioral healthcare Asheville/Gastonia, N.C., May 22, 2026 (GLOBE NEWSWIRE) -- Managed care organizations join to [...]
Regenix Labs Introduces NMN Supplement Designed to Support Cellular Vitality and Healthy Aging
22/05/2026
Educational wellness guide explores NAD+ support, DNA repair support, and long-term cellular wellness routines Regenix Labs: A wellness-focused company committed to ingredient transparency and sustainable healthy aging [...]
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
22/05/2026
PYRUKYND is the only medicine approved in the EU for adults with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia Mitapivat is now approved for thalassemia in the U.S., Saudi Arabia, United [...]
Cuprina Holdings announces 1-for-8 Share Consolidation
22/05/2026
SINGAPORE, May 22, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, [...]
Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class
22/05/2026
With a mean weight loss of 16.6% 1 , Wegovy ® pill demonstrates best-in-class weight-loss efficacy and is the first oral GLP-1 treatment recommended by CHMP for weight management in the EU. CHMP recommends Wegovy ® pill [...]
SafeSpace Global Announces New Senior Living Client; Clearview Healthcare Management, Expanding Deployment Across Seven Tennessee Facilities
22/05/2026
Knoxville, TN., May 22, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation ("SafeSpace" or the "Company") (OTCID: SSGC), a leader in multimodal AI-powered, safety and security solutions, dedicated to safety [...]
BioStem Technologies Announces $2.5 Million Private Placement Financing with its First Institutional Investor
22/05/2026
Strengthening balance sheet on path to Nasdaq uplisting POMPANO BEACH, Fla., May 22, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, [...]
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
22/05/2026
SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026
22/05/2026
Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ongoing Phase 3 study in heavily pre-treated metastatic breast cancer (MBC) [...]
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
22/05/2026
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS Presentation at 2026 TDP43 Summit shows ACI-19626 detects TDP-43 pathology in patients with amyotrophic [...]
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
22/05/2026
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair [...]
SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
22/05/2026
Japanese-Quality Pico Laser Treatment to Serve the Growing Thai Aesthetic Healthcare Market, with Service Launch Scheduled for June 2026 IRVINE, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings [...]
Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
22/05/2026
TARRYTOWN, N.Y., May 22, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the European Medicines Agency (EMA) has accepted for review under Accelerated Assessment the Marketing [...]

Pages